UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

OCTOBER 3, 2013

 Date of Report (Date of earliest event reported)

 

MESA LABORATORIES, INC.

 (Exact name of registrant as specified in its charter)

 

Commission File Number: 0-11740

 

COLORADO

 

84-0872291

(State or other jurisdiction of
incorporation)

 

(I.R.S. Employer
Identification No.)

 

12100 WEST SIXTH AVENUE,

LAKEWOOD, COLORADO

 

80228

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (303) 987-8000

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o                 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 5.07          SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on October 3, 2013.  Of the 3,402,710 shares of common stock entitled to vote, 2,797,279 were represented either in person or proxy.  Seven directors were elected to serve until the next Annual Meeting of Shareholders.  The advisory vote to approve executive compensation was approved.  The shareholders voted, on an advisory basis, as set forth below on the frequency of future advisory votes on executive compensation. The ratification of the appointment of EKS&H LLLP as the Company’s independent auditors for the year ending March 31, 2014 was approved.

 

The seven directors elected were:

 

 

 

 

 

 

 

Broker

 

 

 

For

 

Withheld

 

Non-Votes

 

Luke R. Schmieder

 

1,438,178

 

621,640

 

737,461

 

John J. Sullivan, Ph.D.

 

2,038,934

 

20,884

 

737,461

 

Michael T. Brooks

 

2,018,663

 

41,155

 

737,461

 

H. Stuart Campbell

 

1,899,835

 

159,983

 

737,461

 

Robert V. Dwyer

 

2,028,181

 

31,637

 

737,461

 

Evan C. Guillemin

 

2,019,609

 

40,209

 

737,461

 

David M. Kelly

 

2,021,559

 

38,259

 

737,461

 

 

The advisory vote to approve executive compensation was approved by the following vote:

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Votes

 

1,931,285

 

51,362

 

77,171

 

737,461

 

 

The advisory vote on the frequency of future advisory votes on executive compensation was as follows:

 

Every

 

Every

 

Every

 

 

 

Broker

 

Year

 

2 Years

 

3 Years

 

Abstain

 

Non-Votes

 

1,036,907

 

15,525

 

831,515

 

175,871

 

737,461

 

 

The appointment of EKS&H LLLP as the Company’s independent auditors for the year ending March 31, 2014 was approved by the following vote:

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Votes

 

2,739,226

 

10,472

 

47,581

 

 

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

DATE: October 4, 2013

 

Mesa Laboratories, Inc.

 

 

( Registrant)

 

 

 

 

 

 

 

 

/s/ John J. Sullivan

 

BY:

John J. Sullivan,

 

 

President and Chief Executive Officer

 

3